tetano
Editor, Senior Moderator
Intern Med J
. 2022 Nov 27.
doi: 10.1111/imj.15954. Online ahead of print.
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2
Briony Shaw[SUP] 1 2 [/SUP], Jake Shortt[SUP] 1 2 [/SUP], Michael Low[SUP] 1 2 [/SUP], Benjamin Rogers[SUP] 1 3 [/SUP], Zane Kaplan[SUP] 1 2 [/SUP], Pasquale Fedele[SUP] 1 2 [/SUP], Gareth Gregory[SUP] 1 2 [/SUP], Shahla Vilcassim[SUP] 1 2 [/SUP], Michael Gilbertson[SUP] 1 2 [/SUP], George Grigoriadis[SUP] 1 2 [/SUP], Stephen Opat[SUP] 1 2 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
Keywords: COVID-19; cancer; haematological malignancy; haematological neoplasm; vaccination.
. 2022 Nov 27.
doi: 10.1111/imj.15954. Online ahead of print.
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2
Briony Shaw[SUP] 1 2 [/SUP], Jake Shortt[SUP] 1 2 [/SUP], Michael Low[SUP] 1 2 [/SUP], Benjamin Rogers[SUP] 1 3 [/SUP], Zane Kaplan[SUP] 1 2 [/SUP], Pasquale Fedele[SUP] 1 2 [/SUP], Gareth Gregory[SUP] 1 2 [/SUP], Shahla Vilcassim[SUP] 1 2 [/SUP], Michael Gilbertson[SUP] 1 2 [/SUP], George Grigoriadis[SUP] 1 2 [/SUP], Stephen Opat[SUP] 1 2 [/SUP]
Affiliations
- PMID: 36436197
- DOI: 10.1111/imj.15954
Abstract
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
Keywords: COVID-19; cancer; haematological malignancy; haematological neoplasm; vaccination.